Aquaporin's H1 2025 Results: Strategic Directions and Future Outlook

On August 21, 2025, Aquaporin A/S, a pioneering water technology firm based in Denmark, announced its Half-Year Interim Report summarizing its activities and financials from January 1 to June 30, 2025. Despite facing challenges related to slower-than-expected orders, the company expresses optimism about its commercial potential and strategic growth. CEO Ulrik Lund Jakobsen underscored the need for a robust strategy to enhance the company's balance sheet and navigate future opportunities.

Financial Overview

Aquaporin reported a revenue of DKK 9.1 million for the first half of 2025, a significant decline from DKK 29.2 million during the corresponding period the previous year. However, CFO Klaus Juhl Wulff noted improvements in operational optimization, reinforcing their full-year EBITDA guidance before special items despite posting a loss of DKK 28 million, compared to a loss of DKK 33.5 million in H1 2024. The company holds cash reserves of DKK 29.4 million as of June 30, down from DKK 103.5 million one year prior.

Business Highlights

Among its recent successes, Aquaporin successfully completed a trial with Singapore's National Water Agency (PUB), where its Aquaporin Inside®CLEAR biomimetic membranes demonstrated up to 20% energy savings in reverse osmosis processes, aligning with stringent water quality standards. Additionally, in a proactive step towards leadership continuity, the company appointed Ulrik Lund Jakobsen as CEO effective from July 1, 2025. Jakobsen brings over two decades of experience in technology and engineering sectors, aimed at guiding Aquaporin toward sustained growth and profitability.

In May 2025, Aquaporin made headlines by selling 500 CLEAR membranes to a Beijing firm, enhancing energy efficiency in local wastewater treatment facilities. They also established a pilot plant contract with Trinity College Dublin to advance Forward Osmosis systems, showcasing commitment to research and innovative processes. Their South American presence has also expanded, securing orders to utilize their CLEAR Series for wastewater recycling in Chile and groundwater purification in Mexico.

Strategic Initiatives

In light of their recent performance, Aquaporin is undergoing a strategic review aimed at strengthening its financial position. The company lowered its revenue projections for 2025 from DKK 60-80 million to a new range of DKK 40-50 million, while keeping the EBITDA loss forecast steady at DKK (45)-(55) million. The revised revenue guidance incorporates already recognized revenues and firm commitments, with the majority expected to materialize in the latter half of the year. As part of this repositioning strategy, Aquaporin is exploring options to raise capital, with plans to engage a financial advisor to identify suitable opportunities for growth.

Investor Engagement

An investor webcast is scheduled for August 21, 2025, at 10:00 AM CET, following the report's release. During this session, Aquaporin's management team will present H1 results and engage in a Q&A segment post-presentation. Interested participants can access the webcast via the provided links.

Conclusion

Aquaporin remains committed to innovating in the water technology sphere, endorsed by their biotechnological approaches rooted in nature-inspired solutions. As they navigate current challenges, their focus on strategic growth and operational optimization aims to position them favorably for the future amidst a dynamically shifting market landscape. Aquaporin's dedication to addressing global water challenges remains unwavering, as they strive to enhance water quality and accessibility across various sectors worldwide.